SOMERSET, N.J., Aug. 23, 2007 (PRIME NEWSWIRE) -- Novel Laboratories, LLC, the generic drug joint venture company formed by VGS Pharma, LLC and Elite Pharmaceuticals (AMEX:ELI), announced the filing of Novel’s first Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA).
